BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38000983)

  • 1. Association between unstable diabetes mellitus and risk of pancreatic cancer.
    Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson SA; Spilsbury K; Stewart LM; Thompson B; Tuesley K; Waterhouse M; Webb PM; Jordan SJ; Neale RE
    Pancreatology; 2024 Feb; 24(1):66-72. PubMed ID: 38000983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.
    Dankner R; Murad H; Agay N; Olmer L; Freedman LS
    JAMA Netw Open; 2024 Jan; 7(1):e2350408. PubMed ID: 38175642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.
    Calle EE; Murphy TK; Rodriguez C; Thun MJ; Heath CW
    Cancer Causes Control; 1998 Aug; 9(4):403-10. PubMed ID: 9794172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
    Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based cohort.
    Lin CC; Chiang JH; Li CI; Hsieh TF; Liu CS; Lin WY; Lee YD; Li TC
    Br J Cancer; 2014 Nov; 111(11):2180-6. PubMed ID: 25275365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
    Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
    Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women's Health Study (IWHS) cohort.
    Henry SA; Prizment AE; Anderson KE
    JOP; 2013 May; 14(3):243-9. PubMed ID: 23669472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies.
    Boniol M; Franchi M; Bota M; Leclercq A; Guillaume J; van Damme N; Corrao G; Autier P; Boyle P
    Diabetes Care; 2018 Feb; 41(2):286-292. PubMed ID: 29146599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
    Elena JW; Steplowski E; Yu K; Hartge P; Tobias GS; Brotzman MJ; Chanock SJ; Stolzenberg-Solomon RZ; Arslan AA; Bueno-de-Mesquita HB; Helzlsouer K; Jacobs EJ; LaCroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Bao Y; Boeing H; Boutron-Ruault MC; Buring JE; Gaziano JM; Giovannucci EL; Duell EJ; Hallmans G; Howard BV; Hunter DJ; Hutchinson A; Jacobs KB; Kooperberg C; Kraft P; Mendelsohn JB; Michaud DS; Palli D; Phillips LS; Overvad K; Patel AV; Sansbury L; Shu XO; Simon MS; Slimani N; Trichopoulos D; Visvanathan K; Virtamo J; Wolpin BM; Zeleniuch-Jacquotte A; Fuchs CS; Hoover RN; Gross M
    Cancer Causes Control; 2013 Jan; 24(1):13-25. PubMed ID: 23112111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study.
    Lai HC; Lin CC; Cheng KS; Kao JT; Chou JW; Peng CY; Lai SW; Chen PC; Sung FC
    Gastroenterology; 2014 Jan; 146(1):129-37.e1. PubMed ID: 24095786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
    Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
    Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, Weight Change, and Pancreatic Cancer Risk.
    Yuan C; Babic A; Khalaf N; Nowak JA; Brais LK; Rubinson DA; Ng K; Aguirre AJ; Pandharipande PV; Fuchs CS; Giovannucci EL; Stampfer MJ; Rosenthal MH; Sander C; Kraft P; Wolpin BM
    JAMA Oncol; 2020 Oct; 6(10):e202948. PubMed ID: 32789511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability of pancreatic cancer following diabetes: a population-based study.
    Chari ST; Leibson CL; Rabe KG; Ransom J; de Andrade M; Petersen GM
    Gastroenterology; 2005 Aug; 129(2):504-11. PubMed ID: 16083707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer.
    Dankner R; Freedman LS; Gerstein HC; Roth J; Keinan-Boker L
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3018. PubMed ID: 29673046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer.
    Tseng CM; Wang HH; Wang WL; Lee CT; Tai CM; Tseng CH; Chen CC; Tsai YN; Sun MS; Hsu YC
    Endocr Pract; 2020 Jul; 26(7):707-713. PubMed ID: 33471638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
    Liao KF; Lai SW; Li CI; Chen WC
    J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and pancreatic cancer survival: a prospective cohort-based study.
    Toriola AT; Stolzenberg-Solomon R; Dalidowitz L; Linehan D; Colditz G
    Br J Cancer; 2014 Jul; 111(1):181-5. PubMed ID: 24786605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.
    Oberaigner W; Ebenbichler C; Oberaigner K; Juchum M; Schönherr HR; Lechleitner M
    BMC Public Health; 2014 Oct; 14():1058. PubMed ID: 25300498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
    Everhart J; Wright D
    JAMA; 1995 May 24-31; 273(20):1605-9. PubMed ID: 7745774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.